Baxalta Inc (NYSE:BXLT)’s stock jumped by more than 15% after it reported positive phase three results for its underdevelopment drug BAX 111 and Shire PLC (ADR) (NASDAQ:SHPG)’s unsolicited bid for the …
INSIDER MONKEY · 14 hours ago
Von Willebrand
NEW YORK (TheStreet) -- Baxter International (BAX - Get Report) reported its fiscal 2015 second quarter earnings results after the market close today that beat analysts' estimates. For the latest quarter, the healthcare …
The Street · 7/29/2015
Earnings Results
Baxter International (NYSE:BAX) has been given an “A-” credit rating by analysts at Morningstar. The firm’s “A-” rating indicates that the company is a low default risk. They also gave their stock a three star rating. Several other research ...
Ticker Report · 23 hours ago
More from Bing News
Isis Pharmaceuticals (ISIS): ISIS stock is up 2.7% today. Baxter International Inc (BAX): BAX stock is up 2.8% today. Tenet Healthcare Corp (THC): THC stock is up 3.2% today. Vertex Pharmaceuticals Inc (VRTX): VRTX stock is up 3.1% today. Some of …
Investor Place · 19 hours ago
Baxalta, which was spun off from healthcare company Baxter International Inc. ( BAX) in early July ... in July to acquire Baxalta and combine the two companies in an all-stock transaction valued at about $30 billion. Under the offer, Baxalta shareholders ...
NASDAQ · 6 hours ago
Baxalta (BXLT) is up more than 16% in Tuesday afternoon trading, after Shire (SHPG) made an all-stock offer worth more than $30 billion for the biopharmaceutical firm that was recently spun off from Baxter International …
Barron's · ByTeresa Rivas · 18 hours ago
LONDON (Reuters) - Drugmaker Shire (SHP.L) said on Tuesday it was seeking to buy Baxalta (BXLT.N), a company spun-off by Baxter International (BAX.N) last month ... up nearly 12 percent at $37.10. Shire's stock
Yahoo Finance · ByPaul Sandle · 8 hours ago
Dublin-based Shire SHPG-5.40 % PLC said Tuesday that it has made an unsolicited offer to acquire rare-disease treatment maker Baxalta Inc. BXLT 11.92 % for roughly $30.6 billion in stock ... Baxter International Inc.
Wall Street Journal · 12 hours ago
The brokerage currently has $40.00 price objective on the stock, down from their prior price objective of $82.00. The analysts noted that the move was a valuation call. Shares of Baxter International (NYSE:BAX) opened at 40.08 on Thursday. The stock has a ... · 8/2/2015
Baxter International
Shares of Baxter International (NYSE:BAX) traded up 0.17% during midday trading on Thursday, reaching $40.08. 11,660,315 shares of the company’s stock traded hands. The company has a 50 day moving average of $37.94 and a 200 day moving … · 8/1/2015
Baxter International

Baxter International

Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to tr…
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2013 sales of $15.3 billion, across two businesses: BioScience and Medical Products. Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine; and vaccines. Baxter’s Medical Products business produces intravenous solutions and other products used in the delivery of fluids and drugs to patients; inhalation anesthetics; contract manufacturing services; and products to …
Data from: Wikipedia